Euro Diagnostica

Euro Diagnostica specializes in advanced diagnostic solutions and assay technologies aimed at enhancing drug development and research in healthcare, particularly for inflammatory diseases. Euro Diagnostica was founded in 1992 and is headquartered in Malmo, Sweden. The company focuses on providing innovative assay solutions for the pharmaceutical and biotech sectors. Else Trautner and Jan Collin serve as the CEOs, guiding the company in its strategic direction.

Euro Diagnostica offers a range of advanced products including cell-based iLite reporter gene technology, functional bioassays, and custom development services. These offerings are tailored for clients in drug development and research, helping to diagnose, monitor, and assess various diseases, particularly those related to inflammation. Euro Diagnostica generates revenue primarily through B2B sales of specialized assay solutions and bioanalytical services to clients in the pharmaceutical and biotech industries. The company's core products, including the iLite technology and functional bioassays, represent significant revenue streams, supporting drug development and diagnostic needs.

Looking ahead, Euro Diagnostica aims to enhance its product offerings with new assays targeting emerging therapeutic areas. The company plans to expand its presence in Europe, North America, and Asia by 2025, increasing accessibility to their technologies. Recent funding will support the development of new products and the expansion into these key markets.